Interleukin-5 Antagonist

Name
Interleukin-5 Antagonist
Accession Number
DBCAT003472  (DBCAT004230)
Description

Not Available

Drugs
DrugDrug Description
ReslizumabAn IL-5 antagonist used as an add-on maintenance treatment of patients with severe eosinophilic asthma in adults.
MepolizumabA fully-humanized monoclonal IgG1 kappa anti-IL-5 antibody used in conjunction with other therapies to treat severe asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome.
Drugs & Drug Targets
DrugTargetType
ReslizumabInterleukin-5target
MepolizumabInterleukin-5target